Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma

Background: The effectiveness of cetuximab (CTX) combined with methotrexate (MTX) has not yet been evaluated in patients with recurrent and/or metastatic head-and-neck squamous cell carcinoma (RM-HNSCC). Materials and Methods: A retrospective analysis of patients with RM-HNSCC who received 50 mg MTX...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Chen Tang, Pei-Wei Huang, Chien-Yu Lin, Chia-Hsun Hsieh, Cheng-Lung Hsu, Shiang-Fu Huang, Chun-Ta Liao, Chih-Hua Yeh, Nai-Ming Cheng, Hung-Ming Wang*
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-07-01
Series:Journal of Cancer Research and Practice
Subjects:
cetuximab
head-and-neck squamous cell carcinoma
metastatic
methotrexate
palliative treatment
recurrence
Online Access:https://journals.lww.com/10.4103ejcrp.eJCRP-D-23-00010
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items